2023 World Conference on Lung Cancer (Posters)-EP07.03. Robotic Lung Cancer Program: Initial Experience and Results

EP07.03. Robotic Lung Cancer Program: Initial Experience and Results - PDF(Slides)

Pdf Summary

The study reported the initial experience and results of a robotic lung cancer program. Minimally invasive surgery is the current standard for lung cancer surgery, and robotic surgery is becoming increasingly preferred due to better viewing, ergonomics, and more accurate resections. The study included 209 consecutive patients who underwent robotic resections for thoracic malignancies between December 2018 and March 2023. Of these, 175 were lung cancer cases, which included 6 pneumonectomies, 125 lobectomies, 34 segmental resections, and 10 wedge resections. The mean in-hospital stay was 3.9 days, with chest tube removal occurring at a mean of 2.4 days. Only 1.7% of cases were converted to an open approach. Complications occurred in 18.7% of cases, including pneumonia, arrhythmia, subcutaneous emphysema, quilothorax, acute lung injury, and ischemic stroke. The overall 30-day mortality rate was 1.1%. The mean number of harvested lymph nodes was twenty-two. Positive pleural lavage was observed in 4% of cases. The outcomes of robotic resections were similar to the previous experience with VATS resections, but with a tendency towards shorter length of stay, earlier chest tube removal, lower rates of complications, and lower mortality. The study concludes that robotic lung resection is a safe procedure with several advantages over VATS resection.

Asset Subtitle

Daniel Brandao

Meta Tag

Speaker Daniel Brandao

Topic Early-Stage NSCLC: Limited Resections & Minimally Invasive Approaches

Keywords

robotic lung cancer program

minimally invasive surgery

lung cancer surgery

robotic surgery

viewing

ergonomics

accurate resections

thoracic malignancies

pneumonectomies

lobectomies